This is a phase III randomized study designed to evaluate the efficacy of mitomycin,
doxifluridine, and cisplatin compared to mitomycin and doxifluridine.
Phase:
Phase 3
Details
Lead Sponsor:
Asan Medical Center
Collaborators:
Hallym University Medical Center Ulsan University Hospital